---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-168395"
form_type: "8-K"
ticker: "HURA"
cik: "0001498382"
company_name: "TuHURA Biosciences, Inc./NV"
filed_at: "2026-04-22T23:59:59+00:00"
generated_at: "2026-05-15T04:53:05.312698+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# TuHURA secures $50M credit facility from largest stockholder affiliate to fund operations into Q1 2028

## Summary
- $50M revolving credit facility from Parkview (affiliate of largest stockholder) at 12% interest, matures April 2031.
- Monthly draws capped at greater of $1.7M or monthly budget; expects runway into Q1 2028.
- Commitment fee $5M paid in 1.88M shares (subject to stockholder approval) or cash; annual 1.5% facility fee.
- Granted low-to-mid single digit royalty on IFx-2.0 sales up to $450M/year; warrants extended to 2031.
- Change of control conversion price $2.662/share, requires stockholder approval.

## SEC filing metadata
- accession: 0001193125-26-168395
- form_type: 8-K
- ticker: HURA
- cik: 0001498382
- company_name: TuHURA Biosciences, Inc./NV
- filed_at: 2026-04-22T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1498382/000119312526168395/0001193125-26-168395-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1498382/000119312526168395/d139552d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-168395
- JSON: https://secwatch.observer/filing/0001193125-26-168395.json
- Plain text: https://secwatch.observer/filing/0001193125-26-168395.txt

## Source-grounded claims
- claim_id: 2cec987cbcc10bcadb0861e72aaa25d9b2a4f2ac
  claim: TuHURA Biosciences, Inc./NV incurred revolving credit of $50 million revolving credit facility with Parkview Holdings One LLC at 12% per annum (plus additional 6% during an event of default) maturing April 21, 2031.
  evidence_excerpt: On April 21, 2026, TuHURA Biosciences, Inc. (the “Company”) entered into a Loan Agreement (the “Loan Agreement”) with Parkview Holdings One LLC, as lender (“Parkview”), under which Parkview agreed to extend a $50 million revolving credit facility to the Company upon the terms and conditions set forth in the Loan Agreement.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1498382/000119312526168395/0001193125-26-168395-index.htm
- claim_id: 1fd0ea5b486cde2c912800f48dc211738f82464b
  claim: TuHURA Biosciences, Inc./NV entered into Loan Agreement with Parkview Holdings One LLC valued at $50 million (effective 2026-04-21).
  evidence_excerpt: On April 21, 2026, TuHURA Biosciences, Inc. (the “Company”) entered into a Loan Agreement (the “Loan Agreement”) with Parkview Holdings One LLC, as lender (“Parkview”), under which Parkview agreed to extend a $50 million revolving credit facility to the Company upon the terms and conditions set forth in the Loan Agreement.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1498382/000119312526168395/0001193125-26-168395-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.